Showing 20 of 21 recruiting trials for “Leiomyosarcoma”
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
A Trial for Advanced Leiomyosarcoma With Human Organoid-guided Personalized Efficacy
🏥 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology📍 1 site📅 Started Mar 2026View details ↗
Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma
👨⚕️ Mia C Weiss, M.D., Washington University School of Medicine📍 1 site📅 Started Oct 2025View details ↗
Phase II Decentralized Pragmatic Trial of Adjuvant Doxorubicin - Trabectedin Chemotherapy in uLMS
Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma
👨⚕️ Gabriel Tinoco, MD, Ohio State University Comprehensive Cancer Center📍 1 site📅 Started Sep 2025View details ↗
Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour
XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma
A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions
Letrozole in Uterine Leiomyosarcoma
RecruitingNCT06875700 ↗
Beliefs, Attitudes, and Response to Genetic Testing in SarcomaPatients
RecruitingNCT06749600 ↗
Clinical Management and Outcomes of Primary Ovarian Leiomyosarcoma
Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)
Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo)
RecruitingNCT04925089 ↗
Localized Leiomyosarcoma Biomarker Protocol
👨⚕️ Scott Schuetze, University of Michigan Rogal Cancer Center📍 3 sites📅 Started Apr 2023View details ↗
RecruitingNCT05653388 ↗
Metastatic Leiomyosarcoma Biomarker Protocol
👨⚕️ Scott Schuetze, University of Michigan Rogel Cancer Center📍 11 sites📅 Started Dec 2022View details ↗
AOH1996 for the Treatment of Refractory Solid Tumors
Targeting ATR in Soft-tissue Sarcomas
Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma
Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma
👨⚕️ Sant P Chawla, MD, Sarcoma Oncology Research Center, LLC📍 1 site📅 Started Sep 2021View details ↗
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
🏥 European Organisation for Research and Treatment of Cancer - EORTC📍 164 sites📅 Started Jan 2021View details ↗
Page 1 of 2Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →